2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one

C21H27F3N6O2S — CID 134612004

IUPAC2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one
SMILESO=C1NC(N2CCOCC2)NC(N[C@@H]2CCCNC2)C1c1nc2cc(C(F)(F)F)ccc2s1
InChIInChI=1S/C21H27F3N6O2S/c22-21(23,24)12-3-4-15-14(10-12)27-19(33-15)16-17(26-13-2-1-5-25-11-13)28-20(29-18(16)31)30-6-8-32-9-7-30/h3-4,10,13,16-17,20,25-26,28H,1-2,5-9,11H2,(H,29,31)/t13-,16?,17?,20?/m1/s1
InChIKeyUMVLVWUVHQUPRB-KSMRAORZSA-N
MW484.55 g/mol
LogP1.40
Rot. Bonds4

About 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one

2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one (PubChem CID 134612004) has the molecular formula C21H27F3N6O2S and a molecular weight of 484.55 g/mol. Its IUPAC name is 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one.

Molecular Properties

Compound Name2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one
PubChem CID134612004
Molecular FormulaC21H27F3N6O2S
Molecular Weight484.55 g/mol
Exact Mass484.19
IUPAC Name2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one
SMILESO=C1NC(N2CCOCC2)NC(N[C@@H]2CCCNC2)C1c1nc2cc(C(F)(F)F)ccc2s1
InChIInChI=1S/C21H27F3N6O2S/c22-21(23,24)12-3-4-15-14(10-12)27-19(33-15)16-17(26-13-2-1-5-25-11-13)28-20(29-18(16)31)30-6-8-32-9-7-30/h3-4,10,13,16-17,20,25-26,28H,1-2,5-9,11H2,(H,29,31)/t13-,16?,17?,20?/m1/s1
InChIKeyUMVLVWUVHQUPRB-KSMRAORZSA-N
XLogP1.40
TPSA90.55 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms33
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500484.55
LogP ≤ 51.40
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one?
The IUPAC name of 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one (CID 134612004) is 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one.
What is the SMILES notation for 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one?
The canonical SMILES for 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one is O=C1NC(N2CCOCC2)NC(N[C@@H]2CCCNC2)C1c1nc2cc(C(F)(F)F)ccc2s1.
What is the InChIKey of 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one?
The InChIKey is UMVLVWUVHQUPRB-KSMRAORZSA-N. The full InChI is InChI=1S/C21H27F3N6O2S/c22-21(23,24)12-3-4-15-14(10-12)27-19(33-15)16-17(26-13-2-1-5-25-11-13)28-20(29-18(16)31)30-6-8-32-9-7-30/h3-4,10,13,16-17,20,25-26,28H,1-2,5-9,11H2,(H,29,31)/t13-,16?,17?,20?/m1/s1.
What are the key properties of 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one?
2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one has a molecular weight of 484.55 g/mol, XLogP of 1.40, 4 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 2-morpholin-4-yl-6-[[(3R)-piperidin-3-yl]amino]-5-[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]-1,3-diazinan-4-one is sourced from PubChem (CID 134612004), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).